At MedCity INVEST Digital Health, experts from Jona, Labcorp and Evvy discussed the drivers of consumer diagnostics. The post What’s Driving the Rise of Consumer Diagnostics? appeared first on MedCity News.

BioMarin gains rights to a Fabry disease enzyme replacement therapy with potential dosing advantages over products from Sanofi and Chiesi Group. BioMarin’s new clinical-stage asset could reach patients ineligible for the Fabry drug that came with its Amicus Therapeutics acquisition earlier this year. The post BioMarin Expands Again in Enzyme Replacement, Paying $70M for Long-Acting Fabry Drug appeared first on MedCity News.

Scientific progress only really matters if it changes what life looks like for those living with OCD. That’s because for someone who has spent years losing hours to their obsessions and compulsions, meaningful progress should mean a significant change in their lives. The post Beyond a Score: Putting The Patient Experience at the Heart of OCD Innovation appeared first on MedCity News.

[Sponsored] Pregnancy and NICU admissions are among the most complex areas in healthcare. A new report from ProgenyHealth highlights how the company can work with Medicaid and commercial health plans to uncover insights and hidden risks critical to improving maternal and infant care and reducing costs. The post 3 Ways ProgenyHealth Can Transform Maternity and Infant Health, Claims Management appeared first on MedCity News.

Democratic senators are investigating 10 insurers’ role in the Trump administration’s termination of 760,000 ACA enrollees’ coverage over suspected fraud. The post Senators Investigate Insurers’ Role in Removing Thousands from ACA Coverage appeared first on MedCity News.

Topline Phase 3 results show Eli Lilly’s retatrutide beat Novo’s Ozempic on measures of blood sugar and weight loss in adults with type 2 diabetes. Retatrutide is a peptide designed to activate three metabolic targets versus just one hit by Ozempic. The post Eli Lilly’s ‘Triple-G’ Drug Tops Ozempic in Head-to-Head Type 2 Diabetes Trial appeared first on MedCity News.

With healthcare affordability set to influence voters’ decisions in next week’s midterm elections, the Healthcare Financial Management Association is calling on healthcare leaders to move beyond finger-pointing and work together to address rising costs. HFMA is urging financial leaders across healthcare to sign its Declaration on Healthcare Affordability and Sustainability. The post Ahead of Midterms, HFMA Calls for Cross-Sector Action on Healthcare Affordability appeared first on MedCity News.

By using existing data to better understand members and implementing retention strategies, plans can remain sustainable and members can get the care they need. The post Work Requirements Put New Pressure On Medicaid Member Retention appeared first on MedCity News.

[Sponsored] A webinar sponsored by Inovalon explored how hospitals and pharmacies can work together to generate the best outcomes for patients while improving patient safety. The post How Can Hospitals and Pharmacists Collaborate on Effective Stewardship Programs for Opioids and Antibiotics? appeared first on MedCity News.

Willow Innovations acquired Swehl and Momtech to expand its maternal health offerings beyond breast pumps. The post Willow Acquires 2 Women’s Health Companies appeared first on MedCity News.

Artiva Biotherapeutics attributed one of the fatalities to a drug used to prepare patients for cell therapy and not to the cell therapy itself. But Artiva’s setbacks follow safety signals reported for autoimmune disease cell therapy programs from Novartis and Bristol Myers Squibb. The post Patient Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva appeared first on MedCity News.

As health plans grapple with new federal deadlines for prior authorization decisions, healthcare AI startup ClarityCare has raised $16.5 million to automate the administrative workload that can keep patients waiting for the care they need. The post ClarityCare Raises $16.5M to Speed Up Prior Authorizations  appeared first on MedCity News.

The cost of waiting is not evenly distributed. Rural and critical access hospitals report under 50 percent adoption of even basic predictive tools, compared with 86 percent among top-tier system-affiliated hospitals. Every year without a bridge widens that gap, and it widens it fastest for the hospitals with the least room to absorb it. The post A Market, Not a Mandate, Is the Fastest Way to Bring AI Into Hospitals appeared first on MedCity News.

Women’s health experts had mixed reactions to the Trump administration’s executive order on women’s health. The post How Experts Are Reacting to Trump’s Women’s Health Executive Order appeared first on MedCity News.

Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule could offer better tolerability compared to the rest of its class. The SPAC merger taking Corxel public is expected to close in the first half of 2027, which is when the biotech plans to start a Phase 3 trial. The post Obesity Biotech Corxel Is Going Public in a Merger as Oral GLP-1 Heads to Phase 3 appeared first on MedCity News.